ArticleFrontiers in oncology2026

The STAT3-ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancer.

Tzu-Hua Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.